Similarities And Differences Between The Immunopathogenesis Of Covid-19-Related Pediatric Multisystem Inflammatory Syndrome And Kawasaki Disease

Multisystem inflammatory syndrome associated with the SARS-CoV-2 pandemic has recently been described in children (MIS-C), partially overlapping with Kawasaki disease (KD). We hypothesized that (a) MIS-C and prepandemic KD cytokine profiles may be unique and justify the clinical differences observed, and (b) SARS-CoV-2-specific immune complexes (ICs) may explain the immunopathology of MIS-C. Seventy-four children were included: 14 with MIS-C, 9 patients positive for SARS-CoV-2 by PCR without MIS-C (COVID), 14 with prepandemic KD, and 37 healthy controls (HCs). Thirty-four circulating cytokines were quantified in pretreatment serum or plasma samples and the presence of circulating SARS-CoV-2 ICs was evaluated in MIS-C patients. Compared with HCs, the MIS-C and KD groups showed most cytokines to be significantly elevated, with IFN-gamma-induced response markers (including IFN-gamma, IL-18, and IP-10) and inflammatory monocyte activation markers (including MCP-1, IL-1 alpha, and IL-1RA) being the main triggers of inflammation. In linear discriminant analysis, MIS-C and KD profiles overlapped; however, a subgroup of MIS-C patients (MIS-C-plus) differentiated from the remaining MIS-C patients in IFN-gamma, IL-18, GM-CSF, RANTES, IP-10, IL-1 alpha, and SDF-1 and incipient signs of macrophage activation syndrome. Circulating SARS-CoV-2 ICs were not detected in MIS-C patients. Our findings suggest a major role for IFN-gamma in the pathogenesis of MIS-C, which may be relevant for therapeutic management.